4-Acetamidoacetophenone(Ia),4-acetylbenzenesulfonamide(IIa)and acetohexamide (IIIa) and the respective reduced compounds,4-substituted a-hydroxyethylphenyl derivatives,are in a reversible drug-metabolite relationship in rats.The pharmacokinetic profiles of these agents were studied after intraportal(pv)administration in comparison with those after intravenous(iv) It is important to evaluate the disposition and bioavailability of a drug generated by metabolism after the administration of a prodrug.If the species of interest undergoes reversible biotransformation,the usual concept of drug disposition is not entirely adequate.
(Received May 27,1988) 4-Acetamidoacetophenone(Ia),4-acetylbenzenesulfonamide(IIa)and acetohexamide (IIIa) and the respective reduced compounds,4-substituted a-hydroxyethylphenyl derivatives,are in a reversible drug-metabolite relationship in rats.The pharmacokinetic profiles of these agents were studied after intraportal(pv)administration in comparison with those after intravenous(iv) administration using an interconversion model.Fundamental clearances,CL,o,CL12,CL20 and CL21,were calculated using four AUC(area under the plasma concentration-time curve)values obtained after iv administration of the drug and preformed metabolite.The hepatic available fraction of parent drug,Fin and sequential hepatic available fraction of its metabolite,FH2 were estimated by the following equations. It is important to evaluate the disposition and bioavailability of a drug generated by metabolism after the administration of a prodrug.If the species of interest undergoes reversible biotransformation,the usual concept of drug disposition is not entirely adequate.
Compounds such as sulindac,1) canrenone2) and various corticosteroids and sex steroids34)have metabolites that can revert in part to the parent drug.A complicating factor in pharmacokinetic investigation of these compounds is that reversible metabolism negates the traditional meanings of area under the plasma concentration-time curve(AUC),clearance, distribution volume and bioavailability when these pharmacokinetic parameters are calculated by classical methods.
Previously,5)the authors reported that some 4-substituted a-hydroxyethylphenyl derivatives and the respective oxidized ketones including acetohexamide,an oral antidiabetic agent,were in a reversible drug-metabolite relationship in rats.
The purpose of the present paper is to present comprehensive equations which characterize the pharmacokinetics of a reversible drug-metabolite system using 4-acetamidoacetophenone(Ia), 4- Table  I . X1 and X2 are the amounts of drug in compartment #1 and of metabolite in compartment #2,respectively.The drug(D)may be administered intravenously(iv)into compartment #1 of distribution volume V1 to give a concentration CD.Alternatively,the drug may be Step administered through the portal vein(pv),where Xa is the amount of drug at the administered site,and k is the first-order rate constant describing the drug transfer.The metabolite(M) occupies a distribution volume V2 at compartment #2 to give a concentration CM.CL12 and CL21 are the clearance rates for the metabolic interconversion,and CL10 and CL20 are the clearance rates for the irreversible loss of drug and metabolite,respectively.If drug metabolism occurs in the absence of a reversible process,one can set the opposite clearance (CL21)to be zero.
The fundamental clearances,CL10,CL12,CL20 and CL21 of the system')can be obtained using four A UC values produced after intravenous administration of doses of the drug and preformed metabolite as follows:
After an intraportal dose of drug(Dpv),a certain fraction of Xa enters compartment #1 intact(Fun)escaping hepatic metabolism.A part of the remaining fraction (1-FH1)of Xa undergoes first-pass metabolism,entering the systemic circulation(compartment #2)as the metabolite.The FH2 is the fraction of the generated metabolite which enters compartment #2 escaping sequential hepatic biotransformation.In this system,first-order linear differential equations describing the rates of change across the compartment for the drug and metabolite can be written:
The Laplace transforms8)of the plasma concentration-time equation of the drug eds.) and its metabolite CM(s)after intraportal administration of the drug are given by Eqs.9 and 10,respectively. 
The general solutions for the A UC's under different administration routes of drug and preformed metabolite are summarized in Table II (Eqs.11-16). The rates of systemic available fraction may be defined by Eq.17,dividing Eq.11 by Eq. 13,for the drug,and by Eq.18,dividing Eq.12 by Eq.14,for the generated metabolite:
The relationship described in Eq. 18 may be applicable to a drug-metabolite system in the absence of reversible metabolism.10))
The rate of available fraction as the sum of the drug and its relevant metabolite is given by Eq.19.614 (19) The fraction,CL21/(CL20+CL21)for the first-time conversion of metabolite to parent drug is a fundamental parameter of the interconversion system,7 and may be given by Eq.20, obtained by dividing Eq.16 by Eq.13.
Similarly,CL12/(CL10+ CL12)for the first-time conversion fraction of drug to metabolite may be given by Eq.21,obtained by dividing Eq.14 by Eq.15. a)The rate of available fraction as the sum of drug and its metabolite.
Fundamental Clearances
The fundamental clearances calculated from Eqs.2,3,4 and 5 mentioned above are summarized in Table IV .For the paired agents,la-Ib,the irreversible clearance process for the parent drug,CL10,and the back conversion process,CL21,are similar with values of 0.1381/h per kg.The metabolic process,GL12,operating on lb is larger than CL21,and the irreversible process,CL20 is 1.5 times larger than CL12 with a value of 0.2651/h per kg.An analogous situation may occur in the paired agents,In contrast,it is noticeable that the irreversible process,CL10 is 2 times larger than CL20 for the metabolite,with a value of 0.5881/h per kg,in the case of the paired agents IIa-IIb. When the term [F,2(CL10 CL12)/CL12-1]in Eq.18 mentioned above takes a positive value,Fm is larger than unity.The agents IIa and Ma fall into this category (Table V) .The F values for IIa and IIIa seem to be nearer to unity.Nevertheless,the sequential available fractions,FH2 are appreciably less than unity at 0.87 for IIa and 0.92 for Ma.
In the case of Ia,the FH1,FH2 and F values are 0.72,0.32 and 0.81,respectively,and the value of the term[FH2(CL10+CL12)1CL12-1 .]is negative.
